David Carey

New York

Freelance Contributor at Freelance

Senior Content Advisor for @EdelmanPR. Co-authored King of Capital (Crown), a tale of the rise of Blackstone and private equity. Opinions are mine solely.

Featured in: Favicon

bloomberg.com Favicon

yahoo.com

bmj.com

sagepub.com Favicon

tandfonline.com Favicon

livemint.com Favicon

irishtimes.com Favicon

jamanetwork.com Favicon

globenewswire.com Favicon

dallasnews.com + 99 more

Articles

Hygienic Determinism, Cultural Essentialism, and Public Health in Ecuador and Guatemala, 1900-1950

2 weeks ago | dialnet.unirioja.es | David Carey

Ayuda Buscar en la ayuda Buscar en la ayuda Hygienic Determinism, Cultural Essentialism, and Public Health in Ecuador and Guatemala, 1900-1950 [1] Loyola University, Maryland Localización: EIAL: Estudios Interdisciplinarios de America Latina y el Caribe, ISSN-e 0792-7061, Vol. 34, Nº. 2, 2023, págs.
International-Equity Funds Turn the Tables in Q1 2025

3 weeks ago | morningstar.com | David Carey

US growth stock funds’ winning streak came to an abrupt halt in 2025’s first quarter. Value-oriented funds outperformed their growth counterparts, while international-stock funds fared better than their US peers. Among all equity Morningstar Categories, foreign large-value was among the top performers. Its 7.8% rise beat the foreign large-growth category’s 6.0% return and was much better than the large-value category’s 4.9% gain.
Is This the Long-Awaited Comeback for International-Stock Funds?

1 month ago | morningstar.com | David Carey

The era after the global financial crisis has not been kind to international-equity investors. Over the decade through December 2024, the Morningstar US Market Index’s 12% annualized gain trounced the Morningstar Global Markets ex-US Index’s 5%. Since the beginning of 2025, though, the tides have started to turn. While it’s a short period, the performance discrepancy has been dramatic. Through March 16, 2025, the US benchmark fell 4.3%, while the global ex-US index rose 6.8%.
David Bonderman, Buyout Dealmaker Who Co-Founded TPG, Dies at 82

Dec 11, 2024 | financialpost.com | David Carey |Matthew Griffin |Gillian Tan

Bonderman died on Wednesday, according to a statement from his family and TPG. A cause of death wasn’t cited. Bonderman was a leading member of a generation of financial entrepreneurs who built fledgling buyout shops into Wall Street powerhouses. Others include Henry Kravis, Steve Schwarzman and David Rubenstein. TPG, the firm he started with Jim Coulter in 1992, had $239 billion of assets under management as of Sept. 30, 2024. Bonderman had an eye for unconventional bets.
David Bonderman, Buyout Dealmaker Who Co-Founded TPG, Dies at 82

Dec 11, 2024 | news.bloomberglaw.com | David Carey |Matthew Griffin |Gillian Tan

David Bonderman, the colorful yet publicity-shy co-founder of private equity titan TPG Inc. who became a billionaire by spearheading massive company takeovers, bailouts of foundering enterprises and splashy investments in startups, has died. He was 82. Bonderman died on Wednesday, according to a statement from his family and TPG. A cause of death wasn’t cited.
David Bonderman, Buyout Dealmaker Who Co-Founded TPG, Dies at 82

Dec 11, 2024 | bloomberg.com | David Carey |Matthew Griffin |Gillian Tan

David Bonderman, the colorful yet publicity-shy co-founder of private equity titan TPG Inc. who became a billionaire by spearheading massive company takeovers, bailouts of foundering enterprises and splashy investments in startups, has died. He was 82. Bonderman died on Wednesday, according to a statement from his family and TPG. A cause of death wasn’t cited.
A Checklist for Success at J.P. Morgan Healthcare Conference

Dec 10, 2024 | finnpartners.com | David Carey |Matt Steinberg

News and Insights December 10, 2024 The J.P. Morgan Healthcare Conference (JPM), held each January in San Francisco, is a cornerstone event for healthcare and life sciences industry leaders, drawing innovators, investors, and executives from around the globe. While the main conference provides a platform for publicly traded companies to share updates and insights in high-stakes presentations, the true energy of the week pulses through the myriad satellite meetings happening nearby.
Small-Cap Managers' Big Dilemma With Super Micro Computer

Dec 9, 2024 | morningstar.com | David Carey

Few stocks have ridden the coattails of the artificial intelligence boom like Super Micro Computer. It has been a wild ride for the company and small- and mid-cap stock funds, though, whether or not they owned it. In July 2022, the stock traded for less than USD 5, a volatile and speculative “penny stock.” The server and data storage software company, however, quickly became synonymous with AI, and its shares gained 1,300% between the end of 2022 and its March 2024 peak.
A Not-So-Magnificent Third Quarter for Large-Growth Funds

Oct 2, 2024 | morningstar.com | David Carey

US stocks performed well again in 2024′s third quarter. However, small- and mid-cap equities drove the markets higher this time, not large-cap growth stocks. Of the nine Morningstar Style Box categories, the average fund in the mid-value Morningstar Category gained 9.0% over the quarter, and small-blend funds were up 8.4%. Meanwhile, large-growth funds surrendered the top-performing style box category slot that it held for three consecutive quarters, gaining 3.7%.
Mediation v The Court or ‘Don’t Give Yourself to The Dark Side’

Aug 29, 2024 | lexology.com | David Carey

Probably one of the best ways of approaching mediation is by comparing it to ‘going to court’; after all that is what most parties are expecting. It’s also a good way of educating the parties about what mediation is – and isn’t. Mediation can take place tomorrow. Going to court can, and usually does, take years. Therefore, mediation is less expensive than going to court. Both parties can decide where and when they want to mediate (within reason) e.g. a rented office space for the day.